Emergent Biosolutions's total assets for Q1 2025 were $1.43B, an increase of 2.62% from the previous quarter. EBS total liabilities were $873.40M for the fiscal quarter, a -3.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.